Weismanová E, Sabová L
Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Czechoslovakia.
Neoplasma. 1990;37(6):675-85.
High-molecular-weight DNAs from 5 bladder carcinomas were used in transfection of mouse NIH3T3 cells. The manifestation of heterologous oncogene(s) expression in NIH3T3 cells was morphological transformation very often accompanied by changes in growth characteristics of recipient cells. In DNA samples from secondary NIH3T3 transformants human c-Ha-ras and c-sis sequences were identified. In some secondary transformants these sequences were expressed. On the basis of change of the growth characteristics of some secondary transformants we could expect the integration and expression of another human gene(s) for growth factor or growth factor receptor or even activation of mouse genes. We did not manage to identify any Alu sequences in some secondary transformants carrying human c-Ha-ras sequences. On the other hand, it has not been revealed yet that BamHI DNA fragments carrying c-Ha-ras gene contained any Alu sequence. So, the identification of Alu sequences does not have to be the first step in investigation of DNA samples from NIH3T3 transformants.
从5例膀胱癌中提取的高分子量DNA被用于转染小鼠NIH3T3细胞。NIH3T3细胞中异源癌基因表达的表现通常是形态学转化,并常常伴有受体细胞生长特性的改变。在来自二代NIH3T3转化细胞的DNA样本中鉴定出了人c-Ha-ras和c-sis序列。在一些二代转化细胞中,这些序列得到了表达。基于一些二代转化细胞生长特性的改变,我们可以推测另一个人类生长因子或生长因子受体基因的整合与表达,甚至是小鼠基因的激活。我们未能在一些携带人c-Ha-ras序列的二代转化细胞中鉴定出任何Alu序列。另一方面,尚未发现携带c-Ha-ras基因的BamHI DNA片段含有任何Alu序列。因此,Alu序列的鉴定不一定是研究NIH3T3转化细胞DNA样本的第一步。